• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY Back to Search Results
Model Number 610-001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Abrasion (1789); Corneal Ulcer (1796); Inflammation (1932); Visual Impairment (2138)
Event Date 11/28/2016
Event Type  Injury  
Manufacturer Narrative
The explanted inlay was discarded by the facility and is not available for evaluation.The device history record (dhr) review of the manufacturing lot for this device was performed and there were no discrepancies or unusual findings related to the reported issue.Epithelial defect, recurrent corneal erosion, decreased bcdva, and inlay removal are listed in the device labeling as known potential risks.(b)(4).
 
Event Description
The patient underwent uneventful implantation of the raindrop corneal inlay in the right eye on (b)(6) 2016.Postoperatively the patient developed a persistent non-healing epithelial defect in the operative eye, which was initially located at the superior flap edge and later involved the entire flap surface, approximately 5 mm round.At first onset 2 weeks postoperatively, the patient reported experiencing eye redness, photophobia, and blurred vision with periods of exacerbation and improvement.One month postoperatively the patient was diagnosed with epithelial basement membrane dystrophy (ebmd) in both eyes and the patient disclosed possible eye rubbing.On (b)(6) 2017, the patient presented with recurrent corneal erosion and bcdva decreased to 20/400; the inlay was subsequently explanted on (b)(6) 2017.On april 6, 2017, the patient presented with a neurotropic corneal ulcer and central corneal haze (grade 1-2+); the cornea was cultured and the culture report showed no bacterial or fungal growth.According to the surgeon, the corneal haze was not related to the corneal inlay with onset occurring only after inlay removal.At last examination on (b)(6) 2017, the patient was not improving and the prognosis is guarded.The epithelium has not healed, vision remains 20/400 - hand motion, and a corneal transplant is likely needed.In the surgeon's opinion, the likely causes/contributing factors include subclinical ebmd and the gutter surrounding the corneal flap did not re-epithelialize in an expected manner.
 
Manufacturer Narrative
(b)(4).
 
Event Description
Patient follow-up was requested and the following information was received on (b)(6) 2017.The patient received a therapeutic corneal transplant on (b)(6) 2017.The patient is doing well post transplantation.
 
Manufacturer Narrative
(b)(4).
 
Event Description
Patient follow-up was requested and the following update was received.The patient was examined on (b)(6) 2017 at which time vision had decreased to hand motion with a diagnosis of an acute corneal melt.The patient was referred to a corneal specialist for consideration of emergent penetrating keratoplasty.The most recent update revealed that the corneal melt was able to be controlled with bcdva improving to 20/100 and the eye is quiet with persistent corneal haze.Corneal culture was completed with no growth, but the patient developed 50% hypopyon; cultures were completed again with no growth.A transplant will be considered once the inflammation completely resolves.
 
Manufacturer Narrative
(b)(4).
 
Event Description
The following update was received on october 30, 2017: the corneal transplantation was successful, and the patient experienced a full re-epithelialization of the graft.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAINDROP NEAR VISION INLAY
Type of Device
CORNEAL INLAY
Manufacturer (Section D)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer (Section G)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer Contact
pushpita singh
25651 atlantic ocean dr.,
ste. a1
lake forest, CA 92630-8835
9497072740
MDR Report Key6575636
MDR Text Key75453999
Report Number3005956347-2017-00043
Device Sequence Number1
Product Code LQE
UDI-Device Identifier10850394006013
UDI-Public(01)10850394006013(17)190822(10)002984
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 11/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/18/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date08/22/2019
Device Model Number610-001
Device Catalogue NumberRD1-1
Device Lot Number002984
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/30/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/22/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FEMTOSECOND LASER FOR CREATION OF CORNEAL FLAP
Patient Outcome(s) Disability;
Patient Age56 YR
-
-